PMCB logo

PharmaCyte Biotech (PMCB) Working Capital

Annual Working Capital

$43.02 M
-$24.54 M-36.33%

April 30, 2024

Summary

Performance

1-Year Change

-36.33%

3-Year Change

+2674.67%

5-Year Change

+48165.36%

15-Year Change

+1354.16%

PMCB Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.39%
PMCB annual working capital is higher than 47.39% of companies in Healthcare sector

High & Low

All-time High

$84.79 M
PMCB annual working capital is currently -49.26% below its historical high of $84.79 million

3-Year Low

$1.55 M
PMCB annual working capital is currently +2674.67% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
PMCB previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
PMCB next annual earnings announcement has not yet been scheduled

OtherPMCBbalance sheetmetrics:

Annual Book Value

$27.65 M
PMCB annual book value is $27.65 million

Annual Retained Earnings

-$115.63 M
PMCB annual retained earnings is -$115.63 million

Annual Total Assets

$59.90 M
PMCB annual total assets is $59.90 million

Annual Total Liabilities

$20.39 M
PMCB annual total liabilities is $20.39 million

Quarterly Working Capital

$16.56 M
-$8.85 M-34.82%

October 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-77%

5-Year Change

-77%

PMCB Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.87%
PMCB quarterly working capital is higher than 37.87% of companies in Healthcare sector

High & Low

All-time High

$86.99 M
PMCB quarterly working capital is currently -80.97% below its historical high of $86.99 million

3-Year Low

$16.56 M
PMCB quarterly working capital is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
PMCB previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
PMCB next earnings announcement is scheduled for Mar 18, 2025

OtherPMCBbalance sheetmetrics:

Quarterly Book Value

$43.45 M
PMCB quarterly book value is $43.45 million

Quarterly Retained Earnings

-$93.67 M
PMCB quarterly retained earnings is -$93.67 million

Quarterly Total Assets

$55.10 M
PMCB quarterly total assets is $55.10 million

Quarterly Total Liabilities

$11.65 M
PMCB quarterly total liabilities is $11.65 million

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

Annual Working Capital

$43.02 M
PMCB annual working capital is $43.02 million

Annual Current Assets

$50.44 M
PMCB annual total current assets is $50.44 million

Annual Current Liabilities

$7.42 M
PMCB annual total current liabilities is $7.42 million

PMCB Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-36.3%0.0%
3 y3 years+2674.7%-77.0%
5 y5 years+10000.0%-77.0%

PMCB Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-49.3%+2674.7%-80.8%at low
5 y5-year-49.3%>+9999.0%-81.0%+2144.8%
alltimeall time-49.3%+1409.7%-81.0%+590.5%

PharmaCyte Biotech Working Capital History

DateAnnualQuarterly
Oct 2024
-
$16.56 M(-34.8%)
Jul 2024
-
$25.40 M(-41.0%)
Apr 2024
$43.02 M(-36.3%)
$43.02 M(-20.3%)
Jan 2024
-
$53.97 M(-21.2%)
Oct 2023
-
$68.51 M(-6.5%)
Jul 2023
-
$73.23 M(+8.4%)
Apr 2023
$67.56 M(-20.3%)
$67.56 M(-6.2%)
Jan 2023
-
$71.99 M(-5.2%)
Oct 2022
-
$75.91 M(-6.5%)
Jul 2022
-
$81.17 M(-4.3%)
Apr 2022
$84.79 M(+5368.9%)
$84.79 M(-1.6%)
Jan 2022
-
$86.20 M(-0.9%)
Oct 2021
-
$86.99 M(>+9900.0%)
Jul 2021
-
$583.40 K(-62.4%)
Apr 2021
$1.55 M(>+9900.0%)
$1.55 M(-37.8%)
Jan 2021
-
$2.49 M(-21.3%)
Oct 2020
-
$3.17 M(+175.5%)
Jul 2020
-
$1.15 M(>+9900.0%)
Apr 2020
$6200.00(-106.9%)
$6200.00(-100.8%)
Jan 2020
-
-$809.70 K(+36.2%)
Oct 2019
-
-$594.60 K(+358.8%)
Jul 2019
-
-$129.60 K(+44.8%)
Apr 2019
-$89.50 K(-114.0%)
-$89.50 K(-137.8%)
Jan 2019
-
$236.70 K(-14.0%)
Oct 2018
-
$275.20 K(-74.3%)
Jul 2018
-
$1.07 M(+67.1%)
Apr 2018
$639.70 K(-78.4%)
$639.70 K(-9.8%)
Jan 2018
-
$709.00 K(-68.1%)
Oct 2017
-
$2.22 M(-37.1%)
Jul 2017
-
$3.53 M(+19.3%)
Apr 2017
$2.96 M(+112.3%)
$2.96 M(+55.1%)
Jan 2017
-
$1.91 M(+65.4%)
Oct 2016
-
$1.15 M(-40.5%)
Jul 2016
-
$1.94 M(+39.1%)
Apr 2016
$1.39 M(-47.4%)
$1.39 M(-22.9%)
Jan 2016
-
$1.81 M(+26.2%)
Oct 2015
-
$1.43 M(-21.6%)
Jul 2015
-
$1.83 M(-31.0%)
Apr 2015
$2.65 M(-30.6%)
$2.65 M(+328.1%)
Jan 2015
-
$618.50 K(-38.3%)
Oct 2014
-
$1.00 M(-62.8%)
Jul 2014
-
$2.70 M(-29.2%)
Apr 2014
$3.81 M
$3.81 M(+259.2%)
DateAnnualQuarterly
Jan 2014
-
$1.06 M(-304.7%)
Oct 2013
-
-$518.40 K(-164.0%)
Jul 2013
-
$810.20 K(-141.5%)
Apr 2013
-$1.95 M(-28.5%)
-$1.95 M(-10.8%)
Jan 2013
-
-$2.19 M(-1.1%)
Oct 2012
-
-$2.21 M(-21.6%)
Jul 2012
-
-$2.82 M(+3.4%)
Apr 2012
-$2.73 M(-16.9%)
-$2.73 M(+7.8%)
Jan 2012
-
-$2.53 M(-13.1%)
Oct 2011
-
-$2.91 M(-1.3%)
Jul 2011
-
-$2.95 M(-10.1%)
Apr 2011
-$3.28 M(+8.1%)
-$3.28 M(-2.7%)
Jan 2011
-
-$3.38 M(+2.4%)
Oct 2010
-
-$3.30 M(+1.1%)
Jul 2010
-
-$3.26 M(+7.3%)
Apr 2010
-$3.04 M(-1302.4%)
-$3.04 M(+25.6%)
Jan 2010
-
-$2.42 M(+207.9%)
Oct 2009
-
-$786.40 K(+29.6%)
Jul 2009
-
-$607.00 K(-340.1%)
Apr 2009
$252.80 K(-92.9%)
$252.80 K(-88.8%)
Jan 2009
-
$2.26 M(-19.6%)
Oct 2008
-
$2.81 M(-15.6%)
Jul 2008
-
$3.32 M(-6.5%)
Apr 2008
$3.55 M(+7.3%)
$3.55 M(+6.1%)
Jan 2008
-
$3.35 M(+53.4%)
Oct 2007
-
$2.18 M(-25.5%)
Jul 2007
-
$2.93 M(-11.6%)
Apr 2007
$3.31 M(+9.6%)
$3.31 M(+74.1%)
Jan 2007
-
$1.90 M(-6.1%)
Oct 2006
-
$2.03 M(-15.8%)
Jul 2006
-
$2.41 M(-20.3%)
Apr 2006
$3.02 M(-3664.5%)
$3.02 M(+2953.2%)
Jan 2006
-
$99.00 K(-164.2%)
Oct 2005
-
-$154.10 K(-21.7%)
Jul 2005
-
-$196.90 K(+132.2%)
Apr 2005
-$84.80 K(-165.0%)
-$84.80 K(-111.5%)
Jan 2005
-
$734.90 K(-38.5%)
Oct 2004
-
$1.20 M(-50.4%)
Jul 2004
-
$2.41 M(+1746.8%)
Apr 2004
$130.40 K(-5316.0%)
$130.40 K(+167.8%)
Jan 2004
-
$48.70 K(-969.6%)
Oct 2003
-
-$5600.00(+30.2%)
Jul 2003
-
-$4300.00(+72.0%)
Apr 2003
-$2500.00
-$2500.00

FAQ

  • What is PharmaCyte Biotech annual working capital?
  • What is the all time high annual working capital for PharmaCyte Biotech?
  • What is PharmaCyte Biotech annual working capital year-on-year change?
  • What is PharmaCyte Biotech quarterly working capital?
  • What is the all time high quarterly working capital for PharmaCyte Biotech?
  • What is PharmaCyte Biotech quarterly working capital year-on-year change?

What is PharmaCyte Biotech annual working capital?

The current annual working capital of PMCB is $43.02 M

What is the all time high annual working capital for PharmaCyte Biotech?

PharmaCyte Biotech all-time high annual working capital is $84.79 M

What is PharmaCyte Biotech annual working capital year-on-year change?

Over the past year, PMCB annual working capital has changed by -$24.54 M (-36.33%)

What is PharmaCyte Biotech quarterly working capital?

The current quarterly working capital of PMCB is $16.56 M

What is the all time high quarterly working capital for PharmaCyte Biotech?

PharmaCyte Biotech all-time high quarterly working capital is $86.99 M

What is PharmaCyte Biotech quarterly working capital year-on-year change?

Over the past year, PMCB quarterly working capital has changed by $0.00 (0.00%)